General MedicationsORALStandard
DIACOMIT
STIRIPENTOL
Standard Dose
250MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DIACOMIT is listed in Drugs@FDA under application 207223 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient STIRIPENTOL Form and strength FOR SUSPENSION;ORAL - 250MG/PACKET Sponsor BIOCODEX SA Submission history Latest submission status date: 2022-07-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIACOMIT is listed in Drugs@FDA under application 207223 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient STIRIPENTOL Form and strength FOR SUSPENSION;ORAL - 250MG/PACKET Sponsor BIOCODEX SA Submission history Latest submission status date: 2022-07-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.